Should active injecting drug users receive treatment for chronic hepatitis C? Usuários ativos de drogas injetáveis devem receber tratamento para hepatite crônica tipo C?

CONTEXT: Accumulating data propose that active injecting drug users might not differ from the general population in terms of sustained virological response when adherent to therapy for chronic hepatitis C. However, current guidelines contain restrictive recommendations for therapy in this group of p...

Full description

Bibliographic Details
Main Authors: Vasileios Papadopoulos, Aikaterini Gogou, Theodora Mylopoulou, Konstantinos Mimidis
Format: Article
Language:English
Published: Instituto Brasileiro de Estudos e Pesquisas de Gastroenterologia (IBEPEGE) 2010-09-01
Series:Arquivos de Gastroenterologia
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-28032010000300005